Sharon Rosen


Ms. Rosen is a partner in FBC's Corporate Department.  Ms. Rosen represents public and private clients in general corporate and securities law matters, with an emphasis on international corporate securities matters and cross-border transactions.

Ms. Rosen counsels clients on various types of Israeli and cross-border transactions, including public and private equity and debt offerings, mergers and acquisitions and venture capital investments.

Ms. Rosen provides ongoing corporate and securities law advice to Israeli companies publicly traded in the United States.

Prior to joining FBC, Ms. Rosen was an associate in the Corporate and Securities Department of Carter Ledyard & Milburn in New York and was a member of its Israeli Practice Group, representing Israeli NASDAQ-listed companies on their U.S. securities law compliance and public and private debt and equity offerings.  Prior to that, Ms. Rosen was an associate in the corporate and securities department of a leading Tel Aviv law firm.

Hi-Tech, Technology & Venture Capital

New York, 2005

Israel, 1997

Hebrew University of Jerusalem, LL.B., 1996

Representation of Clermont Energy in its purchase of a $76M convertible note from Eviation Aircraft

FBC represented Clermont Energy Pte. Ltd. in its investment in Eviation Aircraft Ltd., an Israeli company publicly traded in the United States, through a note purchase agreement, pursuant to which Eviation issued to Clermont a convertible promissory note in consideratio...

Ronald Lehmann & Sharon Rosen & Dikla Lavy-Fischer & Ariel Mazer & Avia Dallal & Ute Klose-Goldstein | Jan 2019

Representation of J.P. Morgan and Bank of America in the $442.8 million Private Offering by Ltd. of Convertible Senior Notes

FBC represented J.P. Morgan and Bank of America as Joint Book-Running Managers in the private offering by Ltd. (Nasdaq: WIX) of $442.8 million of 0% Convertible Senior Notes due 2023 (including the exercise in full of an over-allotment option granted to the init...

Michael Zellermayer & Nitzan Sandor & Anat Shavit & Sharon Rosen & Dikla Nassi | Jul 2018

Representation of Frutarom Industries Ltd. in its Acquisition of Enzymotec Ltd.

FBC represented Frutarom Industries Ltd. in its acquisition of Enzymotec Ltd. (NASD: ENZY), for approximately $210 million, at an equity value of approximately $290 million. Enzymotec is a leading global supplier of specialty lipid-based products and solutions. Prior t...

Avraham Well & Sharon Rosen & Anat Shavit & Zohar Liss & Ziv Schwartz & Moran Friedman & Hilla Sachs | Jan 2018
Related News & Publications >>